The efficacy of single dose of pindolol in hypertension. 1977

S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo

The effect of pindolol was studied in 32 patients suffering from hypertension of WHO grad I or II. 25 of these patients respondered to pindolol administered three times daily, and were thereafter treated with a single 20-40 mg dose of pindolol. Normotension was achieved in 15 patients and a satisfactory result in five patients but three patients did not respond to the single dose and two had to interrupt their treatment because of side effects. The side effects were generally mild. As a significant observation NaCl retention was found. It may be due to the preceeding diuretic treatment in most patients, but nevertheless needs further investigations.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
January 1978, Therapie,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
September 1978, La Nouvelle presse medicale,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
August 1977, Revue medicale de la Suisse romande,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
March 1978, European journal of clinical pharmacology,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
September 1978, La Nouvelle presse medicale,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
January 1982, La Clinica terapeutica,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
March 2002, Methods and findings in experimental and clinical pharmacology,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
January 1978, Minerva medica,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
January 1979, La Revue du praticien,
S I Toivonen, and S Mattila, and S Tarpila, and M Leirisalo
April 1977, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
Copied contents to your clipboard!